🔎 Trials Near Me

Hjem › Blodpropper › Louisiana

Kliniske studier for Blodpropper i Louisiana

7 studier for Blodpropper søker deltakere på steder i Louisiana.

Byer i Louisiana

Offisiell studietekst (engelsk)

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

  • Monroe Research, LLC, West Monroe
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07626411

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

  • Monroe Research, LLC, West Monroe
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07175428

Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT

  • CIS Clinical Research, Houma
RekruttererFase 2
Alder 18 til 89 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT04862468

Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

  • Cardiovascular Solutions, Shreveport
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07318610

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

  • Monroe Research, LLC, West Monroe
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07430956

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • Louisiana Center for Bleeding and Clotting Disorders, Tulane University, New Orleans
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT04398628

The CoAGulation Biomarkers and Atrial Fibrillation (COAG-AF) Pilot Study

  • East Jefferson General Hospital, New Orleans
  • University Medical Center, New Orleans
  • Tulane Doctors - Speciality Care - Napoleon, New Orleans
RekruttererObservasjonsstudie
Alder 18 til 120 · Alle kjønn · Oppdatert 5. mar. 2026 · NCT04947657

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.